Overview
ISO 16921-1:2026 – Biotechnology - Gene Delivery Systems - Part 1: Vocabulary is an international standard developed by ISO to establish a common language for gene delivery systems, particularly those used for gene transfer in mammalian systems. This standard covers terminology relating to viral and non-viral gene delivery, as well as mechanical approaches, to support accurate communication in biotechnology research, development, and application. By providing clear and consistent definitions, ISO 16921-1:2026 supports the harmonization of scientific and technical discourse, facilitating innovation and quality in the rapidly evolving field of genetic engineering.
Key Topics
This standard focuses on:
- Core Definitions: Provides standardized terminology for foundational concepts such as gene delivery systems, gene transfer, gene editing, transfection, transduction, and viral vectors.
- Types of Gene Delivery Systems: Covers both viral (e.g., lentivirus, adenovirus, retrovirus) and non-viral (lipid nanoparticles, polymeric carriers, protein nanocarriers) delivery vehicles, along with mechanical methods (e.g., electroporation, microinjection, gene guns).
- System Attributes and Functional Terms: Introduces terms for assessing system attributes such as packaging capacity, cellular uptake, activity, concentration, and cytotoxicity.
- Analytical Methods: Defines terminology essential for the measurement of gene delivery processes, including terms related to accuracy, precision, linearity, sensitivity, and reproducibility.
- Application-Specific Vocabulary: Features terms relating to vectors, payloads, integration strategies (integrating vs. non-integrating systems), and analytical parameters.
Applications
ISO 16921-1:2026 is highly relevant for a range of sectors and activities, including:
- Biotechnology Research and Development: Enables researchers, product developers, and laboratory professionals to use precise and universally understood terminology when designing and testing gene delivery systems.
- Regulatory Submissions and Quality Control: Supports regulatory agencies, compliance officers, and quality assurance professionals in consistently interpreting technical documents, protocols, and reports concerning gene delivery.
- Clinical Applications: Facilitates the clear communication of methods and results in gene therapy, genetic modification, and cellular engineering, enhancing patient safety and treatment efficacy.
- Manufacturing and Technology Transfer: Streamlines the transition from research to production by providing a common vocabulary for manufacturing protocols, validation, and process control in pharmaceutical and biotech industries.
- International Collaboration: Promotes global standardization and interoperability across institutions, enabling effective collaboration, data sharing, and joint ventures in genomic research and biotechnological advancements.
Related Standards
ISO 16921-1:2026 is part of a broader set of standards aimed at the biotechnology sector. Organizations may also reference:
- ISO 5058-1:2021: Biotechnology - Genome editing - Vocabulary, providing complementary terminology for genome editing techniques.
- ISO 20395:2019: Requirements for evaluating the performance of quantification methods for nucleic acid target sequences, useful for analytical methods in gene delivery studies.
- ISO/TS 4958:2024: Nanotechnologies - Vocabulary - Liposomes, which is relevant for non-viral gene delivery systems.
- ISO 20391-1:2018: Biotechnology - Cell counting methods, for guidance on quantifying cellular uptake and activity.
- ISO 23033:2021: Analytical methods for testing and characterization of cellular therapeutic products.
For further definitions, consult the ISO Online Browsing Platform and consider additional ISO standards in biotechnology, genomics, and analytical measurement.
By adopting ISO 16921-1:2026, organizations and professionals can ensure precision, consistency, and international alignment in the language and methodologies applied within the gene delivery field, advancing the broader goals of safety, reliability, and innovation in biotechnology.
